RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,023,000 | +110.7% | 577,900 | +36.7% | 0.00% | – |
Q4 2014 | $960,000 | +16.9% | 422,815 | 0.0% | 0.00% | – |
Q3 2014 | $821,000 | -73.3% | 422,815 | -50.0% | 0.00% | -100.0% |
Q2 2014 | $3,070,000 | +15.1% | 845,630 | +22.9% | 0.00% | -50.0% |
Q1 2014 | $2,668,000 | +36.1% | 687,815 | 0.0% | 0.00% | +100.0% |
Q4 2013 | $1,960,000 | -20.4% | 687,815 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $2,462,000 | +7.2% | 687,815 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $2,297,000 | -16.9% | 687,815 | +69.0% | 0.00% | -50.0% |
Q1 2013 | $2,763,000 | -33.8% | 406,916 | 0.0% | 0.00% | -33.3% |
Q3 2012 | $4,171,000 | +7.4% | 406,916 | +14.7% | 0.00% | 0.0% |
Q2 2012 | $3,882,000 | – | 354,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |